Legence Announces Secondary Underwritten Public Offering of Class A Common Stock
Rhea-AI Summary
Legence (Nasdaq: LGN) announced that selling stockholders affiliated with Blackstone intend to offer 11,000,000 shares of Class A common stock in a secondary underwritten public offering on April 6, 2026. The underwriters have a 30-day option to purchase up to 1,650,000 additional shares.
Legence will not receive proceeds from the sale and will bear offering costs other than underwriting discounts and commissions. The proposed offering is being made from a Form S-1 registration filed April 6, 2026 and is not yet effective.
AI-generated analysis. Not financial advice.
Positive
- Underwritten offering led by Goldman Sachs, Jefferies, and BofA
- Secondary shares include a 30-day overallotment option of 1,650,000 shares
Negative
- Selling stockholders intend to offer 11,000,000 Class A shares
- Legence will not receive any proceeds from the share sale
News Market Reaction – LGN
On the day this news was published, LGN declined 6.12%, reflecting a notable negative market reaction. Argus tracked a trough of -2.6% from its starting point during tracking. Our momentum scanner triggered 13 alerts that day, indicating notable trading interest and price volatility. This price movement removed approximately $413M from the company's valuation, bringing the market cap to $6.34B at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
LGN was down 1.54% with 2 tracked peers (FBGL, OFAL) also moving down (median change about -5.3%), indicating sector-wide pressure alongside this secondary sale headline.
Previous Offering Reports
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 11 | Secondary offering pricing | Negative | -8.9% | Pricing of upsized secondary stock sale by Blackstone-affiliated holders at $45. |
| Dec 09 | Secondary offering launch | Negative | -6.6% | Announcement of 7,000,000-share secondary sale with 30-day underwriter option. |
Previous secondary offerings by Blackstone-affiliated holders on Dec 9, 2025 and Dec 11, 2025 saw price moves of -6.56% and -8.86%, indicating a consistent negative reaction pattern to this news type.
Over the past several months, Legence combined strong operating growth with repeated selling by large shareholders. In December 2025, Blackstone-affiliated holders launched and then priced a secondary offering, both tied to Form S-1 registrations and no proceeds to the company, which pressured shares. Since then, Legence has completed the Bowers acquisition using cash, debt and equity, and reported record 2025 revenue with higher Adjusted EBITDA but ongoing net losses, while raising 2026 guidance and expanding backlog to $3.7 billion. Today’s secondary sale fits into that pattern of sponsor monetization.
Historical Comparison
In the past year, Legence’s two secondary-offering headlines saw an average move of -7.71%, showing a consistently negative response to similar sponsor-sell events.
Blackstone-affiliated holders have repeatedly used secondary underwritten offerings, progressing from a 7,000,000-share launch to an upsized 8,402,178-share sale with full over-allotment exercise.
Market Pulse Summary
The stock moved -6.1% in the session following this news. A negative reaction to this news would be consistent with Legence’s past responses to secondary offerings, which saw moves of -6.56% and -8.86% when Blackstone-affiliated holders sold stock. The current announcement again brings a sizable block of 11,000,000 shares plus a 1,650,000-share option to market, with no proceeds to the company. Investors have also balanced strong backlog and revenue growth against continuing net losses and acquisition-related leverage, which can amplify downside moves.
Key Terms
secondary underwritten public offering financial
par value financial
underwriters financial
prospectus regulatory
Registration Statement on Form S-1 regulatory
AI-generated analysis. Not financial advice.
SAN JOSE, Calif., April 06, 2026 (GLOBE NEWSWIRE) -- Legence Corp. (Nasdaq: LGN) (“Legence” or the “Company”) today announced that selling stockholders affiliated with Blackstone Inc. (the “Selling Stockholders”) intend to offer and sell 11,000,000 shares of Legence’s Class A common stock, par value
Legence is not selling any shares of Common Stock in the offering and will not receive any proceeds from the sale of shares by the Selling Stockholders. Legence will bear the costs associated with the sale of such shares, other than the underwriting discounts and commissions.
Goldman Sachs & Co. LLC, Jefferies and BofA Securities are acting as joint lead book-running managers and Blackstone Capital Markets is acting as a co-manager for the proposed offering.
The proposed offering will be made only by means of a prospectus. Copies of the preliminary prospectus, when available, may be obtained from: Goldman Sachs & Co. LLC, Attn: Prospectus Department, 200 West Street, New York, NY 10282, by telephone at 1-866-471-2526, or by email at prospectus-ny@ny.email.gs.com; Jefferies LLC, Attn: Equity Syndicate Prospectus Department, 520 Madison Avenue, New York, NY 10022, by telephone at 1-877-821-7388, or by email at prospectus_department@jefferies.com; and BofA Securities, 201 North Tryon Street, Charlotte, NC 28255-0001, Attn: Prospectus Department, or by email at dg.prospectus_requests@bofa.com.
The shares of Common Stock are being offered pursuant to a Registration Statement on Form S-1 filed with the Securities and Exchange Commission (the “SEC”) on April 6, 2026 (the “Registration Statement”), which has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the Registration Statement becomes effective. This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended.
About Legence
Legence is a leading provider of engineering, consulting, installation, and maintenance services for mission-critical systems in buildings. The Company specializes in designing, fabricating, and installing complex HVAC, process piping, and other mechanical, electrical and plumbing (MEP) systems—enhancing energy efficiency, reliability, and sustainability in new and existing facilities. Legence also delivers long-term performance through strategic upgrades and holistic solutions. Serving some of the world’s most technically demanding sectors, Legence counts over
Forward-Looking Statements
Certain statements contained in this press release constitute “forward-looking statements.” All statements, other than statements of historical fact, included in this press release, including, without limitation, those relating to the size, timing or other terms of the offering, are forward-looking statements. When used in this press release, words such as “anticipate,” “assume,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “future,” “will,” “seek,” “foreseeable,” the negative version of these words and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words. These statements are not historical facts but rather are based on management’s current belief, based on currently available information, as to the outcome and timing of future events, and it is possible that the results described in this press release will not be achieved. Such statements are subject to risks, uncertainties and other factors, many of which are outside of Legence’s control, that could cause actual results to differ materially from the results discussed in the forward-looking statements, including, but not limited to, those described under “Risk Factors” in the Registration Statement and “Item 1A. Risk Factors” in Legence’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the “2025 Annual Report”), as filed with the SEC, as such factors may be updated from time to time in Legence’s subsequent filings with the SEC. Any forward-looking statement speaks only as of the date on which it is made, and, except as required by law, Legence does not undertake any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for Legence to predict all such factors. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements in the Registration Statement, the 2025 Annual Report and in Legence’s subsequent filings with the SEC. You are cautioned not to place undue reliance on these forward-looking statements.
Contact
Media: media@wearelegence.com
Investor Relations: ir@wearelegence.com
